133 related articles for article (PubMed ID: 21636996)
1. LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice.
Gu J; Zuo J; Lei L; Zhao H; Sun C; Feng X; Du C; Li X; Yang Y; Han W
Bioeng Bugs; 2011; 2(2):96-9. PubMed ID: 21636996
[TBL] [Abstract][Full Text] [Related]
2. LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation.
Zhang L; Li D; Li X; Hu L; Cheng M; Xia F; Gong P; Wang B; Ge J; Zhang H; Cai R; Wang Y; Sun C; Feng X; Lei L; Han W; Gu J
Sci Rep; 2016 Jul; 6():29344. PubMed ID: 27385518
[TBL] [Abstract][Full Text] [Related]
3. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
[TBL] [Abstract][Full Text] [Related]
4. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.
Gu J; Xu W; Lei L; Huang J; Feng X; Sun C; Du C; Zuo J; Li Y; Du T; Li L; Han W
J Clin Microbiol; 2011 Jan; 49(1):111-7. PubMed ID: 21048011
[TBL] [Abstract][Full Text] [Related]
5. An Ointment Consisting of the Phage Lysin LysGH15 and Apigenin for Decolonization of Methicillin-Resistant
Cheng M; Zhang L; Zhang H; Li X; Wang Y; Xia F; Wang B; Cai R; Guo Z; Zhang Y; Ji Y; Sun C; Feng X; Lei L; Yang Y; Han W; Gu J
Viruses; 2018 May; 10(5):. PubMed ID: 29734776
[No Abstract] [Full Text] [Related]
6. Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus.
Nguyen QT; Furuya Y; Roberts S; Metzger DW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6308-16. PubMed ID: 26248370
[TBL] [Abstract][Full Text] [Related]
7. Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus.
Xia F; Li X; Wang B; Gong P; Xiao F; Yang M; Zhang L; Song J; Hu L; Cheng M; Sun C; Feng X; Lei L; Ouyang S; Liu ZJ; Li X; Gu J; Han W
Appl Environ Microbiol; 2016 Jan; 82(1):87-94. PubMed ID: 26475103
[TBL] [Abstract][Full Text] [Related]
8. [Protective effect of pretreatment with TLR2 agonist Pam3Csk4 on mice challenged by methicillin-resistant Staphylococcus aureus].
Chen Y; Chen H; Deng L; Gui X; Yu L; Xiong Z; Min W; Wu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):212-6. PubMed ID: 26927383
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma plays a detrimental role in murine defense against nasal colonization of Staphylococcus aureus.
Satorres SE; Alcaráz LE; Cargnelutti E; Di Genaro MS
Immunol Lett; 2009 Apr; 123(2):185-8. PubMed ID: 19428568
[TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
Desbois AP; Gemmell CG; Coote PJ
Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
[TBL] [Abstract][Full Text] [Related]
11. The application of the lytic domain of endolysin from Staphylococcus aureus bacteriophage in milk.
Yan J; Yang R; Yu S; Zhao W
J Dairy Sci; 2021 Mar; 104(3):2641-2653. PubMed ID: 33358804
[TBL] [Abstract][Full Text] [Related]
12. An innate bactericidal oleic acid effective against skin infection of methicillin-resistant Staphylococcus aureus: a therapy concordant with evolutionary medicine.
Chen CH; Wang Y; Nakatsuji T; Liu YT; Zouboulis C; Gallo R; Zhang L; Hsieh MF; Huang CM
J Microbiol Biotechnol; 2011 Apr; 21(4):391-9. PubMed ID: 21532323
[TBL] [Abstract][Full Text] [Related]
13. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.
Kruszewska D; Sahl HG; Bierbaum G; Pag U; Hynes SO; Ljungh A
J Antimicrob Chemother; 2004 Sep; 54(3):648-53. PubMed ID: 15282239
[TBL] [Abstract][Full Text] [Related]
14. Anti-infectious activity of synbiotics in a novel mouse model of methicillin-resistant Staphylococcus aureus infection.
Lkhagvadorj E; Nagata S; Wada M; Bian L; Wang C; Chiba Y; Yamashiro Y; Shimizu T; Asahara T; Nomoto K
Microbiol Immunol; 2010 May; 54(5):265-75. PubMed ID: 20536723
[TBL] [Abstract][Full Text] [Related]
15. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan.
Ahn JY; Song JY; Yun YS; Jeong G; Choi IS
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):187-97. PubMed ID: 16487300
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus: the superbug.
Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
[TBL] [Abstract][Full Text] [Related]
17. Effect of IL-10 antisense gene therapy in severely burned mice intradermally infected with MRSA.
Asai A; Kogiso M; Kobayashi M; Herndon DN; Suzuki F
Immunobiology; 2012 Jul; 217(7):711-8. PubMed ID: 22209112
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.
Bouza E
Clin Microbiol Infect; 2009 Dec; 15 Suppl 7():44-52. PubMed ID: 19951334
[TBL] [Abstract][Full Text] [Related]
19. Focus: methicillin-resistant Staphylococus aureus (MRSA). Introduction.
Reygaert W
Clin Lab Sci; 2009; 22(2):109-10. PubMed ID: 19534444
[No Abstract] [Full Text] [Related]
20. Current challenges in treating MRSA: what are the options?
Ratnaraja NV; Hawkey PM
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
